<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7509820\results\search\disease\results.xml">
  <result pre="CentralLondon pmcid: 7509820322 doi: 10.1186/s13027-020-00322-7 : Review Clinical management of" exact="lung cancer" post="patients during the outbreak of COVID-19 epidemic WangLiJiangManQuJialinZhouNaZhangXiaochunzhangxiaochun9670@126.com[], grid.410645.20000"/>
  <result pre="pmcid: 7509820322 doi: 10.1186/s13027-020-00322-7 : Review Clinical management of lung" exact="cancer" post="patients during the outbreak of COVID-19 epidemic WangLiJiangManQuJialinZhouNaZhangXiaochunzhangxiaochun9670@126.com[], grid.410645.20000"/>
  <result pre="the word just a few months. The outbreak of COVID-19" exact="infection" post="poses major threat to international health and economy. World"/>
  <result pre="with the spread of COVID-19, the routine medical care of" exact="lung cancer" post="patients was affected. Because lung cancer patients have low"/>
  <result pre="the spread of COVID-19, the routine medical care of lung" exact="cancer" post="patients was affected. Because lung cancer patients have low"/>
  <result pre="routine medical care of lung cancer patients was affected. Because" exact="lung cancer" post="patients have low immunity after anti-tumor treatment, they should"/>
  <result pre="medical care of lung cancer patients was affected. Because lung" exact="cancer" post="patients have low immunity after anti-tumor treatment, they should"/>
  <result pre="treatment, they should become the main targets for epidemic prevention." exact="Lung cancer" post="patients are increasingly concerned about the prevention of COVID-19."/>
  <result pre="they should become the main targets for epidemic prevention. Lung" exact="cancer" post="patients are increasingly concerned about the prevention of COVID-19."/>
  <result pre="is necessary to provide individualized medical treatment and management for" exact="lung cancer" post="patients based on patientsâ€™ conditions and regional epidemic patterns."/>
  <result pre="necessary to provide individualized medical treatment and management for lung" exact="cancer" post="patients based on patientsâ€™ conditions and regional epidemic patterns."/>
  <result pre="based on patientsâ€™ conditions and regional epidemic patterns. Keywords COVID-19" exact="Lung cancer" post="Patient management Funding Taishan Scholar Foundation of Shandong Province"/>
  <result pre="on patientsâ€™ conditions and regional epidemic patterns. Keywords COVID-19 Lung" exact="cancer" post="Patient management Funding Taishan Scholar Foundation of Shandong Province"/>
  <result pre="including alpha-, beta-, gamma-, and delta-coronavirus [1]. Coronaviruses mainly cause" exact="infections" post="in birds and mammals and, in recent decades, also"/>
  <result pre="infecting humans [2]. The outbreak of beta- coronavirus including severe" exact="acute" post="respiratory syndrome coronavirus (SARS) in 2002 [3] and Middle"/>
  <result pre="humans [2]. The outbreak of beta- coronavirus including severe acute" exact="respiratory" post="syndrome coronavirus (SARS) in 2002 [3] and Middle East"/>
  <result pre="[2]. The outbreak of beta- coronavirus including severe acute respiratory" exact="syndrome" post="coronavirus (SARS) in 2002 [3] and Middle East respiratory"/>
  <result pre="respiratory syndrome coronavirus (SARS) in 2002 [3] and Middle East" exact="respiratory" post="syndrome coronavirus (MERS) in 2012 [4] has confirmed that"/>
  <result pre="syndrome coronavirus (SARS) in 2002 [3] and Middle East respiratory" exact="syndrome" post="coronavirus (MERS) in 2012 [4] has confirmed that the"/>
  <result pre="type and the B type is derived from Type A," exact="Type C" post="are derived from Type B. Nearly half of the"/>
  <result pre="is derived from Type A, Type C are derived from" exact="Type B." post="Nearly half of the samples infected with Type A"/>
  <result pre="mainly in the United States and Australia, and two-thirds of" exact="American" post="samples are infected with Type A, and Type B"/>
  <result pre="two-thirds of American samples are infected with Type A, and" exact="Type B" post="is the most common in East Asia. type C"/>
  <result pre="and Type B is the most common in East Asia." exact="type C" post="is the main virus type spread in Europe [18]."/>
  <result pre="C is the main virus type spread in Europe [18]." exact="Lung cancer" post="was the most incident and lethal malignant tumor among"/>
  <result pre="is the main virus type spread in Europe [18]. Lung" exact="cancer" post="was the most incident and lethal malignant tumor among"/>
  <result pre="Europe [18]. Lung cancer was the most incident and lethal" exact="malignant" post="tumor among all human cancers, with an estimated that"/>
  <result pre="[18]. Lung cancer was the most incident and lethal malignant" exact="tumor" post="among all human cancers, with an estimated that there"/>
  <result pre="an estimated that there are about 234,030 new cases with" exact="lung cancer" post="in the United States in 2018 [19]. There are"/>
  <result pre="estimated that there are about 234,030 new cases with lung" exact="cancer" post="in the United States in 2018 [19]. There are"/>
  <result pre="States in 2018 [19]. There are a large number of" exact="lung cancer" post="patients. With the prevalence of COVID-19 epidemic, the routine"/>
  <result pre="in 2018 [19]. There are a large number of lung" exact="cancer" post="patients. With the prevalence of COVID-19 epidemic, the routine"/>
  <result pre="the prevalence of COVID-19 epidemic, the routine medical care of" exact="lung cancer" post="patients was affected. Moreover, lung cancer patients are more"/>
  <result pre="prevalence of COVID-19 epidemic, the routine medical care of lung" exact="cancer" post="patients was affected. Moreover, lung cancer patients are more"/>
  <result pre="routine medical care of lung cancer patients was affected. Moreover," exact="lung cancer" post="patients are more susceptible to COVID-19 since they are"/>
  <result pre="medical care of lung cancer patients was affected. Moreover, lung" exact="cancer" post="patients are more susceptible to COVID-19 since they are"/>
  <result pre="minimize the effect of the epidemic, providing clinical management for" exact="lung cancer" post="patients in the global epidemic scenario is an urgent"/>
  <result pre="the effect of the epidemic, providing clinical management for lung" exact="cancer" post="patients in the global epidemic scenario is an urgent"/>
  <result pre="epidemiological characteristics, early diagnosis, patient management and mental health of" exact="lung cancer" post="patients during the COVID-19 epidemic. Molecular mechanism The Coronavirus"/>
  <result pre="characteristics, early diagnosis, patient management and mental health of lung" exact="cancer" post="patients during the COVID-19 epidemic. Molecular mechanism The Coronavirus"/>
  <result pre="(HE protein) and RNA. The spike protein of coronaviruses facilitates" exact="viral" post="entry into target cells. The spike protein is a"/>
  <result pre="viral entry into target cells. The spike protein is a" exact="type I" post="transmembrane glycoprotein and can be divided into two functional"/>
  <result pre="domain (RBD) domain and the N-terminal domain [21]. S1 facilitates" exact="virus infection" post="by binding to host receptors. And S2 is responsible"/>
  <result pre="(RBD) domain and the N-terminal domain [21]. S1 facilitates virus" exact="infection" post="by binding to host receptors. And S2 is responsible"/>
  <result pre="of spike protein [22]. Angiotensin-converting enzyme 2 (ACE2) is a" exact="type I" post="membrane protein mainly expressed in the lung, heart, kidney"/>
  <result pre="through polar residues [32]. The structural information of ACE2 is" exact="limited" post="to the PD domain. So, the S protein of"/>
  <result pre="So, the S protein of COVID-19 exploit ACE2 for host" exact="infection" post="[33â€&quot;36]. COVID-19 invade the human body by combine to"/>
  <result pre="days [38]. The main route transmission of COVID-19 is through" exact="respiratory" post="droplets and close contact. A study found viruses in"/>
  <result pre="non-pneumonia, respectively [38]. Laboratory features of patients usually include leukopenia," exact="lymphopenia" post="and elevated aspartate aminotransferase. Compared with ICU patients, non-ICU"/>
  <result pre="elevated aspartate aminotransferase. Compared with ICU patients, non-ICU patients had" exact="lower" post="plasma levels of IL2, IL7, IL10, GSCF, IP10, MCP1,"/>
  <result pre="IL7, IL10, GSCF, IP10, MCP1, MIP1A, and TNFÎ± [14]. COVID-19" exact="pneumonia" post="baseline chest CT presented with ground glass opacities (72%),"/>
  <result pre="GSCF, IP10, MCP1, MIP1A, and TNFÎ± [14]. COVID-19 pneumonia baseline" exact="chest" post="CT presented with ground glass opacities (72%), consolidation (13%),"/>
  <result pre="60â€‰years age and suffer from underlying diseases such as hypertension," exact="cardiovascular disease" post="and cancer [42]. Epidemiological characteristics of COVID-19 with neoplasm"/>
  <result pre="age and suffer from underlying diseases such as hypertension, cardiovascular" exact="disease" post="and cancer [42]. Epidemiological characteristics of COVID-19 with neoplasm"/>
  <result pre="suffer from underlying diseases such as hypertension, cardiovascular disease and" exact="cancer" post="[42]. Epidemiological characteristics of COVID-19 with neoplasm Chinese center"/>
  <result pre="cardiovascular disease and cancer [42]. Epidemiological characteristics of COVID-19 with" exact="neoplasm" post="Chinese center for disease control and prevention [40] has"/>
  <result pre="[42]. Epidemiological characteristics of COVID-19 with neoplasm Chinese center for" exact="disease" post="control and prevention [40] has shown that 72,314 cases"/>
  <result pre="control and prevention [40] has shown that 72,314 cases of" exact="pneumonia" post="were reported, including confirmed cases (61.8%), suspected cases (22.4%),"/>
  <result pre="(61.8%), suspected cases (22.4%), clinically diagnosed cases (14.6%), and asymptomatic" exact="infections" post="(1.2%). About 107 (0.5%) were cancer patients, of which"/>
  <result pre="cases (14.6%), and asymptomatic infections (1.2%). About 107 (0.5%) were" exact="cancer" post="patients, of which 6 deaths, and the crude mortality"/>
  <result pre="2020, 18 (1%) had a history of cancer, 28% of" exact="cancer" post="patient were lung cancer patients. Cancer patients have a"/>
  <result pre="had a history of cancer, 28% of cancer patient were" exact="lung cancer" post="patients. Cancer patients have a higher risk of serious"/>
  <result pre="a history of cancer, 28% of cancer patient were lung" exact="cancer" post="patients. Cancer patients have a higher risk of serious"/>
  <result pre="of cancer, 28% of cancer patient were lung cancer patients." exact="Cancer" post="patients have a higher risk of serious events than"/>
  <result pre="Pâ€‰=â€‰0.000,3), and symptoms deteriorate more rapidly. Early identification of COVID-19" exact="pneumonia" post="in lung cancer patients The symptoms of lung cancer"/>
  <result pre="symptoms deteriorate more rapidly. Early identification of COVID-19 pneumonia in" exact="lung cancer" post="patients The symptoms of lung cancer patients include cough,"/>
  <result pre="deteriorate more rapidly. Early identification of COVID-19 pneumonia in lung" exact="cancer" post="patients The symptoms of lung cancer patients include cough,"/>
  <result pre="of COVID-19 pneumonia in lung cancer patients The symptoms of" exact="lung cancer" post="patients include cough, sputum, dyspnea, and fever. After anti-tumor"/>
  <result pre="COVID-19 pneumonia in lung cancer patients The symptoms of lung" exact="cancer" post="patients include cough, sputum, dyspnea, and fever. After anti-tumor"/>
  <result pre="have various treatment-related side effects. Moreover, the imageology detection of" exact="lung cancer" post="is not typical due to influence of the tumor."/>
  <result pre="various treatment-related side effects. Moreover, the imageology detection of lung" exact="cancer" post="is not typical due to influence of the tumor."/>
  <result pre="it is very difficult to identify and diagnose the COVID-19" exact="pneumonia" post="early. It is necessary to actively improve the relevant"/>
  <result pre="differential diagnosis, and clarify the cause. The diagnosis of COVID-19" exact="pneumonia" post="needs to be combined with the epidemiological history and"/>
  <result pre="epidemiological history and clinical manifestations (â‘ fever and / or" exact="respiratory" post="symptoms; â‘¡ with imaging features of COVID-19 pneumonia; â‘¢"/>
  <result pre="decreased lymphocyte count in the early stage of the disease)." exact="General" post="virus detection Cell culture Traditional cell isolation and culture"/>
  <result pre="convenient and fast operation, and suitable for screening of hidden" exact="infections" post="and large-scale people. Serological tests often show these symptoms"/>
  <result pre="human blood within 15â€‰min which can detect patients at different" exact="infection" post="stages [45]. Nucleic acid detection The characteristics of nucleic"/>
  <result pre="RT-PCR Real-time RT-PCR is widely deployed in diagnostic virology. In" exact="acute" post="respiratory infection, RT-PCR is routinely used to detect causative"/>
  <result pre="Real-time RT-PCR is widely deployed in diagnostic virology. In acute" exact="respiratory" post="infection, RT-PCR is routinely used to detect causative viruses"/>
  <result pre="infection, RT-PCR is routinely used to detect causative viruses from" exact="respiratory" post="secretions [46]. A study [47] successfully detects COVID-19, and"/>
  <result pre="an important role in the initial diagnosis of COVID-19 pneumonia." exact="Multiple" post="patchy ground glass opacities in bilateral multiple lobular with"/>
  <result pre="diagnosis of COVID-19 pneumonia. Multiple patchy ground glass opacities in" exact="bilateral" post="multiple lobular with periphery distribution are typical chest CT"/>
  <result pre="COVID-19 pneumonia. Multiple patchy ground glass opacities in bilateral multiple" exact="lobular" post="with periphery distribution are typical chest CT imaging features"/>
  <result pre="opacities in bilateral multiple lobular with periphery distribution are typical" exact="chest" post="CT imaging features of the COVID-19 pneumonia [41]. Differential"/>
  <result pre="distribution are typical chest CT imaging features of the COVID-19" exact="pneumonia" post="[41]. Differential diagnosis of lung cancer patients For lung"/>
  <result pre="imaging features of the COVID-19 pneumonia [41]. Differential diagnosis of" exact="lung cancer" post="patients For lung cancer patients, it is very important"/>
  <result pre="features of the COVID-19 pneumonia [41]. Differential diagnosis of lung" exact="cancer" post="patients For lung cancer patients, it is very important"/>
  <result pre="COVID-19 pneumonia [41]. Differential diagnosis of lung cancer patients For" exact="lung cancer" post="patients, it is very important to make a differential"/>
  <result pre="pneumonia [41]. Differential diagnosis of lung cancer patients For lung" exact="cancer" post="patients, it is very important to make a differential"/>
  <result pre="to make a differential diagnosis and fully assess whether the" exact="lung cancer" post="patients have other possibilities of causing fever and respiratory"/>
  <result pre="make a differential diagnosis and fully assess whether the lung" exact="cancer" post="patients have other possibilities of causing fever and respiratory"/>
  <result pre="lung cancer patients have other possibilities of causing fever and" exact="respiratory" post="symptoms. Radiation pneumonia Radiation pneumonia can occur in lung"/>
  <result pre="have other possibilities of causing fever and respiratory symptoms. Radiation" exact="pneumonia" post="Radiation pneumonia can occur in lung cancer patients 1â€‰month"/>
  <result pre="possibilities of causing fever and respiratory symptoms. Radiation pneumonia Radiation" exact="pneumonia" post="can occur in lung cancer patients 1â€‰month to 3â€‰months"/>
  <result pre="and respiratory symptoms. Radiation pneumonia Radiation pneumonia can occur in" exact="lung cancer" post="patients 1â€‰month to 3â€‰months after radiotherapy, and some case"/>
  <result pre="respiratory symptoms. Radiation pneumonia Radiation pneumonia can occur in lung" exact="cancer" post="patients 1â€‰month to 3â€‰months after radiotherapy, and some case"/>
  <result pre="also become unspecific. This makes it difficult to distinguish radiation" exact="pneumonia" post="from COVID-19 pneumonia. We need a multidisciplinary team in"/>
  <result pre="team in the radiotherapy department, imaging department, oncology department, and" exact="infection" post="department to fully analyze the radiotherapy time, radiotherapy dose,"/>
  <result pre="patientâ€™s specific clinical manifestations and test results. Immune checkpoint inhibitor-associated" exact="pneumonia" post="There is a risk of immune checkpoint inhibitor-associated pneumonia"/>
  <result pre="inhibitor-associated pneumonia There is a risk of immune checkpoint inhibitor-associated" exact="pneumonia" post="in patients who receiving immunotherapy. The clinical symptoms of"/>
  <result pre="receiving immunotherapy. The clinical symptoms of the immune checkpoint inhibitor-associated" exact="pneumonia" post="including fever, increased cough and sputum, and increased dyspnea."/>
  <result pre="[49]. This also requires multidisciplinary cooperation including oncology, imaging, and" exact="infectious diseases," post="comprehensive analysis and identification, and guidance for subsequent treatment."/>
  <result pre="diseases, comprehensive analysis and identification, and guidance for subsequent treatment." exact="Tumor" post="progression Tumor progression may lead to obstructive pneumonia, cancerous"/>
  <result pre="analysis and identification, and guidance for subsequent treatment. Tumor progression" exact="Tumor" post="progression may lead to obstructive pneumonia, cancerous lymphadenitis, pleural"/>
  <result pre="progression Tumor progression may lead to obstructive pneumonia, cancerous lymphadenitis," exact="pleural" post="effusion increased, pericardial effusion, etc., which can lead to"/>
  <result pre="may lead to obstructive pneumonia, cancerous lymphadenitis, pleural effusion increased," exact="pericardial effusion," post="etc., which can lead to fever and respiratory symptoms."/>
  <result pre="increased, pericardial effusion, etc., which can lead to fever and" exact="respiratory" post="symptoms. Chest and abdomen CT and tumor markers can"/>
  <result pre="to fever and respiratory symptoms. Chest and abdomen CT and" exact="tumor" post="markers can assist in differential diagnosis. Regular examination of"/>
  <result pre="tumor markers can assist in differential diagnosis. Regular examination of" exact="lung cancer" post="patients Patients with regular examination after lung cancer surgery"/>
  <result pre="markers can assist in differential diagnosis. Regular examination of lung" exact="cancer" post="patients Patients with regular examination after lung cancer surgery"/>
  <result pre="examination of lung cancer patients Patients with regular examination after" exact="lung cancer" post="surgery can delay the examination if the condition is"/>
  <result pre="of lung cancer patients Patients with regular examination after lung" exact="cancer" post="surgery can delay the examination if the condition is"/>
  <result pre="delay the examination if the condition is stable. For advanced" exact="lung cancer" post="patients with targeted therapy or immunotherapy, the scheduled examination"/>
  <result pre="the examination if the condition is stable. For advanced lung" exact="cancer" post="patients with targeted therapy or immunotherapy, the scheduled examination"/>
  <result pre="scheduled examination can be postponed or postponed according to the" exact="cancer" post="status. The interval between examinations can be extended to"/>
  <result pre="can be extended to more than 3â€‰months for patients with" exact="symptomatic" post="remission or stable disease. It is recommended that patients"/>
  <result pre="to more than 3â€‰months for patients with symptomatic remission or" exact="stable" post="disease. It is recommended that patients continue to take"/>
  <result pre="certain effects in COVID-19 therapy. According to Chinaâ€™s New Coronavirus" exact="Pneumonia" post="Diagnosis and Treatment Plan (Trial Version 8), drugs with"/>
  <result pre="used as a boosted protease inhibitor in the treatment of" exact="HIV infection" post="[50]. Lopinavir and ritonavir can block the enzymes that"/>
  <result pre="as a boosted protease inhibitor in the treatment of HIV" exact="infection" post="[50]. Lopinavir and ritonavir can block the enzymes that"/>
  <result pre="[54]. In addition, Remdesivir can improve lung function, reduce lung" exact="viral" post="load and severe lung pathology in mice [51]. A"/>
  <result pre="lung pathology in mice [51]. A study reported that an" exact="American" post="patient with COVID-19 survived by treated with Remdesivir [55]."/>
  <result pre="discussion. Chloroquine and Hydroxychloroquine Chloroquine, a widely used antimalarial and" exact="autoimmune disease" post="drug, has been reported may be a potential broad-spectrum"/>
  <result pre="Chloroquine and Hydroxychloroquine Chloroquine, a widely used antimalarial and autoimmune" exact="disease" post="drug, has been reported may be a potential broad-spectrum"/>
  <result pre="be a potential broad-spectrum antiviral drug [57, 58]. Chloroquine blocks" exact="viral infection" post="by increasing endosomal pH required for virus fusion, and"/>
  <result pre="a potential broad-spectrum antiviral drug [57, 58]. Chloroquine blocks viral" exact="infection" post="by increasing endosomal pH required for virus fusion, and"/>
  <result pre="and chloroquine are highly effective in the control of COVID-19" exact="infection" post="in vitro [60]. Therefore, the efficacy of Chloroquine needs"/>
  <result pre="shortened in hydroxychloroquine group. The proportion of patients with improved" exact="pneumonia" post="was 80.6%, which was higher than that of the"/>
  <result pre="not recommended for COVID-19 patients base on Chinaâ€™s New Coronavirus" exact="Pneumonia" post="Diagnosis and Treatment Plan (Trial Version 8). Convalescent plasma"/>
  <result pre="immunization, a technique to achieve immediate short-term immunization, to against" exact="infectious" post="agents by administering pathogen-specific antibodies [62]. Human blood was"/>
  <result pre="blood or plasma from patients who has survived in previous" exact="infection" post="and produce humoral immune against the disease [65]. Convalescent"/>
  <result pre="survived in previous infection and produce humoral immune against the" exact="disease" post="[65]. Convalescent plasma is widely used after large-scale epidemics"/>
  <result pre="I clinical trial showed that 10 patients with severe COVID-19" exact="pneumonia" post="had all symptoms, especially fever, cough, shortness of breath,"/>
  <result pre="had all symptoms, especially fever, cough, shortness of breath, and" exact="chest" post="pain, improved within 3â€‰days after infusion of plasma from"/>
  <result pre="plasma from recovered patients, and laboratory tests, Imaging performance and" exact="viral" post="load have improved significantly [68]. In addition, convalescent plasma"/>
  <result pre="In addition, convalescent plasma is suitable for patients with rapid" exact="disease" post="progression, severe and critically ill patients base on Chinaâ€™s"/>
  <result pre="severe and critically ill patients base on Chinaâ€™s New Coronavirus" exact="Pneumonia" post="Diagnosis and Treatment Plan (Trial Version 8). The infusion"/>
  <result pre="of critically ill patients with COVID-19 showed that administration of" exact="systemic" post="corticosteroids, compared with usual care or placebo, was associated"/>
  <result pre="corticosteroids, compared with usual care or placebo, was associated with" exact="lower" post="28-day all-cause mortality [69]. Nowadays, According to Chinaâ€™s New"/>
  <result pre="28-day all-cause mortality [69]. Nowadays, According to Chinaâ€™s New Coronavirus" exact="Pneumonia" post="Diagnosis and Treatment Plan (Trial Version 8), the patients"/>
  <result pre="the bodyâ€™s inflammatory response, glucocorticoids should be used in a" exact="short" post="period of time. The recommended dose is equivalent to"/>
  <result pre="corticosteroids in severe and critical covid-19 because there is a" exact="lower" post="risk of death among people treated with systemic corticosteroids"/>
  <result pre="is a lower risk of death among people treated with" exact="systemic" post="corticosteroids [70]. Traditional Chinese medicine Lianhuaqingwen capsule is an"/>
  <result pre="antipyretic and anti-inflammatory, cough and phlegm, and regulates immunity against" exact="viral" post="respiratory infection equal effect [71]. More and more studies"/>
  <result pre="and anti-inflammatory, cough and phlegm, and regulates immunity against viral" exact="respiratory" post="infection equal effect [71]. More and more studies showed"/>
  <result pre="anti-inflammatory, cough and phlegm, and regulates immunity against viral respiratory" exact="infection" post="equal effect [71]. More and more studies showed that"/>
  <result pre="against various RNA viruses (including influenza, Ebola, CoV and Venezuelan" exact="Equine" post="Encephalitis Virus (VEEV)) has broad-spectrum antiviral activity [74â€&quot;76]. A"/>
  <result pre="various RNA viruses (including influenza, Ebola, CoV and Venezuelan Equine" exact="Encephalitis" post="Virus (VEEV)) has broad-spectrum antiviral activity [74â€&quot;76]. A study"/>
  <result pre="therapeutic administration of NHC/EIDD-2801 can improve lung function and reduce" exact="viral" post="titer and weight loss [77]. The efficacy and oral"/>
  <result pre="Tocilizumab Tocilizumab is an immunosuppressive drug, mainly used to treat" exact="rheumatoid arthritis" post="and systemic juvenile idiopathic arthritis. It is a humanized"/>
  <result pre="Tocilizumab is an immunosuppressive drug, mainly used to treat rheumatoid" exact="arthritis" post="and systemic juvenile idiopathic arthritis. It is a humanized"/>
  <result pre="an immunosuppressive drug, mainly used to treat rheumatoid arthritis and" exact="systemic" post="juvenile idiopathic arthritis. It is a humanized monoclonal antibody"/>
  <result pre="immunosuppressive drug, mainly used to treat rheumatoid arthritis and systemic" exact="juvenile idiopathic arthritis." post="It is a humanized monoclonal antibody against interleukin 6"/>
  <result pre="IL-6 is associated with the mortality of patients with COVID-19" exact="infection" post="pneumonia [78]. A recent study showed that all patients"/>
  <result pre="is associated with the mortality of patients with COVID-19 infection" exact="pneumonia" post="[78]. A recent study showed that all patients experienced"/>
  <result pre="of Tocilizumab, and 90% of patients experienced a reduction in" exact="pulmonary" post="symptoms. According to Chinaâ€™s New Coronavirus Pneumonia Diagnosis and"/>
  <result pre="a reduction in pulmonary symptoms. According to Chinaâ€™s New Coronavirus" exact="Pneumonia" post="Diagnosis and Treatment Plan (Trial Version 8), Tocilizumab can"/>
  <result pre="Version 8), Tocilizumab can be tried for patients with extensive" exact="lung disease" post="and elevated IL-6 levels in the laboratory. The first"/>
  <result pre="8), Tocilizumab can be tried for patients with extensive lung" exact="disease" post="and elevated IL-6 levels in the laboratory. The first"/>
  <result pre="of Tocilizumab is 4-8â€‰mg/kg, and the recommended dose is 400â€‰mg." exact="Lung cancer" post="patients awaiting treatment For lung cancer patients who have"/>
  <result pre="Tocilizumab is 4-8â€‰mg/kg, and the recommended dose is 400â€‰mg. Lung" exact="cancer" post="patients awaiting treatment For lung cancer patients who have"/>
  <result pre="recommended dose is 400â€‰mg. Lung cancer patients awaiting treatment For" exact="lung cancer" post="patients who have not yet begun to medical treatment,"/>
  <result pre="dose is 400â€‰mg. Lung cancer patients awaiting treatment For lung" exact="cancer" post="patients who have not yet begun to medical treatment,"/>
  <result pre="the treatment strategy should be comprehensively considered baseed on the" exact="tumor" post="burden and general situation of the patient. For early-stage"/>
  <result pre="tumor burden and general situation of the patient. For early-stage" exact="lung cancer" post="patients who waiting for surgery, the operation time should"/>
  <result pre="burden and general situation of the patient. For early-stage lung" exact="cancer" post="patients who waiting for surgery, the operation time should"/>
  <result pre="it has little effect on the overall condition in the" exact="short" post="term. The specific situation should be based on specific"/>
  <result pre="pathology, clinical stage and prognostic indicators. A study showed that" exact="lung cancer" post="patients who recover slowly from lung cancer surgery may"/>
  <result pre="clinical stage and prognostic indicators. A study showed that lung" exact="cancer" post="patients who recover slowly from lung cancer surgery may"/>
  <result pre="study showed that lung cancer patients who recover slowly from" exact="lung cancer" post="surgery may still benefit from delayed adjuvant chemotherapy started"/>
  <result pre="showed that lung cancer patients who recover slowly from lung" exact="cancer" post="surgery may still benefit from delayed adjuvant chemotherapy started"/>
  <result pre="which may reduce side effects of chemotherapy and the cross" exact="infection" post="caused by repeated hospital visits [80]. Lung cancer patients"/>
  <result pre="and the cross infection caused by repeated hospital visits [80]." exact="Lung cancer" post="patients receiving chemotherapy Lung cancer patients undergoing chemotherapy may"/>
  <result pre="the cross infection caused by repeated hospital visits [80]. Lung" exact="cancer" post="patients receiving chemotherapy Lung cancer patients undergoing chemotherapy may"/>
  <result pre="by repeated hospital visits [80]. Lung cancer patients receiving chemotherapy" exact="Lung cancer" post="patients undergoing chemotherapy may not be able to receive"/>
  <result pre="repeated hospital visits [80]. Lung cancer patients receiving chemotherapy Lung" exact="cancer" post="patients undergoing chemotherapy may not be able to receive"/>
  <result pre="The main concern in these patients is the development of" exact="tumor" post="due to ingenuity of chemotherapy. Therefore, while we attach"/>
  <result pre="the adverse effects of this epidemic on chemotherapy delays in" exact="lung cancer" post="patients, we should also regard the adjustment of chemotherapy"/>
  <result pre="adverse effects of this epidemic on chemotherapy delays in lung" exact="cancer" post="patients, we should also regard the adjustment of chemotherapy"/>
  <result pre="regimen rationally. We recommend the patients who with a low" exact="tumor" post="burden, stable disease, and receiving postoperative adjuvant chemotherapy and"/>
  <result pre="We recommend the patients who with a low tumor burden," exact="stable" post="disease, and receiving postoperative adjuvant chemotherapy and maintenance treatment"/>
  <result pre="recommended that individual treatment under the guidance of an oncologist." exact="Lung cancer" post="patients receiving targeted therapy Targeted therapies are revolutionized therapeutics"/>
  <result pre="that individual treatment under the guidance of an oncologist. Lung" exact="cancer" post="patients receiving targeted therapy Targeted therapies are revolutionized therapeutics"/>
  <result pre="are revolutionized therapeutics which interfere with specific molecules to block" exact="cancer" post="growth, progression, and metastasis [81]. Targeted therapy is recommended"/>
  <result pre="interfere with specific molecules to block cancer growth, progression, and" exact="metastasis" post="[81]. Targeted therapy is recommended for patients with advanced"/>
  <result pre="metastasis [81]. Targeted therapy is recommended for patients with advanced" exact="lung cancer" post="with the mutations of targeted driver EGFR, BRAF or"/>
  <result pre="[81]. Targeted therapy is recommended for patients with advanced lung" exact="cancer" post="with the mutations of targeted driver EGFR, BRAF or"/>
  <result pre="be caused by targeted therapies in the current epidemic situation." exact="Lung cancer" post="patients who take oral targeted therapy drugs and have"/>
  <result pre="caused by targeted therapies in the current epidemic situation. Lung" exact="cancer" post="patients who take oral targeted therapy drugs and have"/>
  <result pre="cancer patients who take oral targeted therapy drugs and have" exact="stable" post="conditions should maintain the original drug treatment during the"/>
  <result pre="whose condition improved markedly after targeted therapy and those with" exact="stable" post="disease can be appropriately deferred to the hospital for"/>
  <result pre="condition improved markedly after targeted therapy and those with stable" exact="disease" post="can be appropriately deferred to the hospital for review"/>
  <result pre="an oncologist under proper protection under emergency symptoms or obvious" exact="disease" post="progression. Lung cancer patients receiving immunotherapy Immunotherapy has become"/>
  <result pre="under proper protection under emergency symptoms or obvious disease progression." exact="Lung cancer" post="patients receiving immunotherapy Immunotherapy has become an innovative technology"/>
  <result pre="proper protection under emergency symptoms or obvious disease progression. Lung" exact="cancer" post="patients receiving immunotherapy Immunotherapy has become an innovative technology"/>
  <result pre="patients receiving immunotherapy Immunotherapy has become an innovative technology for" exact="lung cancer" post="therapy with the discovery of immunological checkpoints. It has"/>
  <result pre="receiving immunotherapy Immunotherapy has become an innovative technology for lung" exact="cancer" post="therapy with the discovery of immunological checkpoints. It has"/>
  <result pre="It has shown great potential in a variety of advanced" exact="cancer" post="treatments [83]. Drug binds to PD-1 molecule and generate"/>
  <result pre="pathway-mediated, including anti-tumor immune response [84]. We suggest that for" exact="lung cancer" post="patients who receiving immunotherapy during the epidemic, it is"/>
  <result pre="including anti-tumor immune response [84]. We suggest that for lung" exact="cancer" post="patients who receiving immunotherapy during the epidemic, it is"/>
  <result pre="immunotherapy on a set date. Considering the adverse events of" exact="pulmonary" post="event caused by immunotherapeutic drugs, immunotherapy can be suspended"/>
  <result pre="drugs, immunotherapy can be suspended or postponed in patients with" exact="stable" post="disease. Management of adverse events Some lung cancer patients"/>
  <result pre="in patients with stable disease. Management of adverse events Some" exact="lung cancer" post="patients who receiving antitumor treatment such as chemotherapy, targeted"/>
  <result pre="patients with stable disease. Management of adverse events Some lung" exact="cancer" post="patients who receiving antitumor treatment such as chemotherapy, targeted"/>
  <result pre="dizziness, the patient should be taken to the hospital for" exact="symptomatic" post="treatment. Routine blood examination should be continue in the"/>
  <result pre="Routine blood examination should be continue in the management of" exact="lung cancer" post="patients during antitumor treatment to monitor the extent of"/>
  <result pre="blood examination should be continue in the management of lung" exact="cancer" post="patients during antitumor treatment to monitor the extent of"/>
  <result pre="cancer patients during antitumor treatment to monitor the extent of" exact="myelosuppression" post="through the important concerns including platelets, leukocyte counts, neutrophils,"/>
  <result pre="and red blood cells and hemoglobin levels. Mild to moderate" exact="myelosuppression" post="can be treated with corresponding oral drugs. However, there"/>
  <result pre="over 60â€‰years age and suffer from underlying diseases such as" exact="cancer" post="[42]. Some studies have shown that about half of"/>
  <result pre="studies have shown that about half of the survivors of" exact="malignant" post="tumors have moderate fear of cancer recurrence [87]. Meantime,"/>
  <result pre="of the survivors of malignant tumors have moderate fear of" exact="cancer" post="recurrence [87]. Meantime, Fujita et al. found that 9.1%"/>
  <result pre="recurrence [87]. Meantime, Fujita et al. found that 9.1% of" exact="lung cancer" post="patients suffered anxiety and requested a treatment delay during"/>
  <result pre="[87]. Meantime, Fujita et al. found that 9.1% of lung" exact="cancer" post="patients suffered anxiety and requested a treatment delay during"/>
  <result pre="et al. found that 9.1% of lung cancer patients suffered" exact="anxiety" post="and requested a treatment delay during the COVID-19 pandemic"/>
  <result pre="delay during the COVID-19 pandemic [88]. Coupled with the epidemic," exact="lung cancer" post="patients may more worry about the impact of COVID-19"/>
  <result pre="during the COVID-19 pandemic [88]. Coupled with the epidemic, lung" exact="cancer" post="patients may more worry about the impact of COVID-19"/>
  <result pre="anti-tumor treatmen, which makes them more susceptible to illness, anxiety," exact="depression" post="and insomnia. Calvo et al. found that health surveillance"/>
  <result pre="of receiving COVID-19 information and news was associated with a" exact="lower" post="risk of anxiety [90]. It is recommended high risk"/>
  <result pre="information and news was associated with a lower risk of" exact="anxiety" post="[90]. It is recommended high risk patients be identified"/>
  <result pre="(MHADRO) to assist with screening for mental health problems for" exact="cancer" post="patients [92]. Therefore, It is necessary to provide health"/>
  <result pre="[92]. Therefore, It is necessary to provide health services to" exact="cancer" post="patients during COVID-19 pandemic, in order to prevent the"/>
  <result pre="COVID-19 pandemic, in order to prevent the predictable decline of" exact="cancer" post="conditions, and prevent health system overload and health control"/>
  <result pre="on the epidemiological characteristics, early diagnosis and patient management of" exact="lung cancer" post="patients during the COVID-19 epidemic. We provide helpful advice"/>
  <result pre="the epidemiological characteristics, early diagnosis and patient management of lung" exact="cancer" post="patients during the COVID-19 epidemic. We provide helpful advice"/>
  <result pre="advice for the alternative transitional treatment and clinical management for" exact="lung cancer" post="patients during the epidemic. Publisherâ€™s Note Springer Nature remains"/>
  <result pre="for the alternative transitional treatment and clinical management for lung" exact="cancer" post="patients during the epidemic. Publisherâ€™s Note Springer Nature remains"/>
  <result pre="current knowledgeVirol J20191616910.1186/s12985-019-1182-031133031 3.KsiazekTGet al.A novel coronavirus associated with severe" exact="acute" post="respiratory syndromeNew England J Med2003348201953196610.1056/NEJMoa03078112690092 4.ZakiAMet al.Isolation of a"/>
  <result pre="knowledgeVirol J20191616910.1186/s12985-019-1182-031133031 3.KsiazekTGet al.A novel coronavirus associated with severe acute" exact="respiratory" post="syndromeNew England J Med2003348201953196610.1056/NEJMoa03078112690092 4.ZakiAMet al.Isolation of a novel"/>
  <result pre="4.ZakiAMet al.Isolation of a novel coronavirus from a man with" exact="pneumonia" post="in Saudi ArabiaNew England J Med2012367191814182010.1056/NEJMoa121172123075143 5.collab: World Health"/>
  <result pre="July 20032003 6.Ayelech M. Cross sectional study of middle east" exact="respiratory" post="syndrome coronavirus in selected kebeles of yabello district of"/>
  <result pre="20032003 6.Ayelech M. Cross sectional study of middle east respiratory" exact="syndrome" post="coronavirus in selected kebeles of yabello district of borena"/>
  <result pre="(New York, NY)2020367647523423510.1126/science.367.6475.234 9.ZhuNet al.A novel coronavirus from patients with" exact="pneumonia" post="in China, 2019N Engl J Med2020382872773310.1056/NEJMoa200101731978945 10.ChenYLiuQGuoDEmerging coronaviruses: genome"/>
  <result pre="2019 Novel coronavirus in Wuhan, ChinaLancet (London, England)20203951022349750610.1016/S0140-6736(20)30183-5 15.ChanJF-Wet al.A" exact="familial" post="cluster of pneumonia associated with the 2019 novel coronavirus"/>
  <result pre="in Wuhan, ChinaLancet (London, England)20203951022349750610.1016/S0140-6736(20)30183-5 15.ChanJF-Wet al.A familial cluster of" exact="pneumonia" post="associated with the 2019 novel coronavirus indicating person-to-person transmission:"/>
  <result pre="genomesProc Natl Acad Sci U S A202011717924110.1073/pnas.200499911732269081 19.SiegelRLMillerKDJemalACancer statistics, 2018CA" exact="Cancer" post="J Clin201868110.3322/caac.21416 20.LiFStructure, function, and evolution of coronavirus spike"/>
  <result pre="receptor-binding subunitsJ Virol20128652856285822205743 22.GlowackaIet al.Evidence that TMPRSS2 activates the severe" exact="acute" post="respiratory syndrome coronavirus spike protein for membrane fusion and"/>
  <result pre="subunitsJ Virol20128652856285822205743 22.GlowackaIet al.Evidence that TMPRSS2 activates the severe acute" exact="respiratory" post="syndrome coronavirus spike protein for membrane fusion and reduces"/>
  <result pre="Virol20128652856285822205743 22.GlowackaIet al.Evidence that TMPRSS2 activates the severe acute respiratory" exact="syndrome" post="coronavirus spike protein for membrane fusion and reduces viral"/>
  <result pre="respiratory syndrome coronavirus spike protein for membrane fusion and reduces" exact="viral" post="control by the humoral immune responseJ Virol20118594122413421325420 23.DonoghueMet al.A"/>
  <result pre="spike in the prefusion conformationScience (New York, NY)20203676483126010.1126/science.abb2507 34.ZhouPet al.A" exact="pneumonia" post="outbreak associated with a new coronavirus of probable bat"/>
  <result pre="al.Air, surface environmental, and personal protective equipment contamination by severe" exact="acute" post="respiratory syndrome coronavirus 2 (SARS-CoV-2) from a symptomatic patientJAMA202032316161010.1001/jama.2020.322732129805"/>
  <result pre="surface environmental, and personal protective equipment contamination by severe acute" exact="respiratory" post="syndrome coronavirus 2 (SARS-CoV-2) from a symptomatic patientJAMA202032316161010.1001/jama.2020.322732129805 40.NovelCPThe"/>
  <result pre="environmental, and personal protective equipment contamination by severe acute respiratory" exact="syndrome" post="coronavirus 2 (SARS-CoV-2) from a symptomatic patientJAMA202032316161010.1001/jama.2020.322732129805 40.NovelCPThe epidemiological"/>
  <result pre="by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from a" exact="symptomatic" post="patientJAMA202032316161010.1001/jama.2020.322732129805 40.NovelCPThe epidemiological characteristics of an outbreak of 2019"/>
  <result pre="application of a rapid IgM-IgG combined antibody test for SARS-CoV-2" exact="infection" post="diagnosis. J Med Virol. 2020. 10.1002/jmv.25727. Published online ahead"/>
  <result pre="and research priorities in immune checkpoint inhibitor-related pneumonitis. An official" exact="American" post="Thoracic Society research statementAm J Respir Crit Care Med20192006e31e4310.1164/rccm.201906-1202ST31518182"/>
  <result pre="research priorities in immune checkpoint inhibitor-related pneumonitis. An official American" exact="Thoracic" post="Society research statementAm J Respir Crit Care Med20192006e31e4310.1164/rccm.201906-1202ST31518182 50.TsangKZhongNSSARS:"/>
  <result pre="D, et al. Compassionate Use of Remdesivir for Patients with" exact="Severe" post="Covid-19. N Engl J Med. 2020;382(24):2327-2336. 10.1056/NEJMoa2007016. 57.SavarinoAet al.New"/>
  <result pre="Dis200662676910.1016/S1473-3099(06)70361-916439323 58.YanYet al.Anti-malaria drug chloroquine is highly effective in treating" exact="avian influenza" post="a H5N1 virus infection in an animal modelCell Res201323230030210.1038/cr.2012.16523208422"/>
  <result pre="chloroquine is highly effective in treating avian influenza a H5N1" exact="virus infection" post="in an animal modelCell Res201323230030210.1038/cr.2012.16523208422 59.VincentMJet al.Chloroquine is a"/>
  <result pre="is highly effective in treating avian influenza a H5N1 virus" exact="infection" post="in an animal modelCell Res201323230030210.1038/cr.2012.16523208422 59.VincentMJet al.Chloroquine is a"/>
  <result pre="Res201323230030210.1038/cr.2012.16523208422 59.VincentMJet al.Chloroquine is a potent inhibitor of SARS coronavirus" exact="infection" post="and spreadVirol J200526910.1186/1743-422X-2-6916115318 60.WangMet al.Remdesivir and chloroquine effectively inhibit"/>
  <result pre="Transfus201614215215726674811 63.RajamGet al.An augmented passive immune therapy to treat fulminant" exact="bacterial" post="infectionsRecent Patents Anti-infect Drug Discov201052157167 64.KellerMAStiehmERPassive immunity in prevention"/>
  <result pre="Anti-infect Drug Discov201052157167 64.KellerMAStiehmERPassive immunity in prevention and treatment of" exact="infectious" post="diseasesClin Microbiol Rev200013460261411023960 65.BurnoufTSeghatchianJEbola virus convalescent blood products: where"/>
  <result pre="Research, GState of knowledge and data gaps of Middle East" exact="respiratory" post="syndrome coronavirus (MERS-CoV) in humansPLoS Curr201351 67.WongVWSet al.Treatment of"/>
  <result pre="GState of knowledge and data gaps of Middle East respiratory" exact="syndrome" post="coronavirus (MERS-CoV) in humansPLoS Curr201351 67.WongVWSet al.Treatment of severe"/>
  <result pre="syndrome coronavirus (MERS-CoV) in humansPLoS Curr201351 67.WongVWSet al.Treatment of severe" exact="acute" post="respiratory syndrome with convalescent plasmaHong Kong Med J20039319919]12777656 68.DuanKet"/>
  <result pre="coronavirus (MERS-CoV) in humansPLoS Curr201351 67.WongVWSet al.Treatment of severe acute" exact="respiratory" post="syndrome with convalescent plasmaHong Kong Med J20039319919]12777656 68.DuanKet al.Effectiveness"/>
  <result pre="(MERS-CoV) in humansPLoS Curr201351 67.WongVWSet al.Treatment of severe acute respiratory" exact="syndrome" post="with convalescent plasmaHong Kong Med J20039319919]12777656 68.DuanKet al.Effectiveness of"/>
  <result pre="Acad Sci U S A202011717949032253318 69.SterneJACet al.Association between Administration of" exact="Systemic" post="Corticosteroids and Mortality among critically ill patients with COVID-19:"/>
  <result pre="compound that induces a high level of mutations in the" exact="viral" post="genomeJ Virol2018923 76.AgostiniMLet al.Small-molecule antiviral Î²-d--Hydroxycytidine inhibits a proofreading-intact"/>
  <result pre="al.An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway" exact="epithelial" post="cell cultures and multiple coronaviruses in miceSci Transl Med20201254110.1126/scitranslmed.abb5883"/>
  <result pre="multiple coronaviruses in miceSci Transl Med20201254110.1126/scitranslmed.abb5883 78.ZhangCet al.The cytokine release" exact="syndrome" post="(CRS) of severe COVID-19 and Interleukin-6 receptor (IL-6R) antagonist"/>
  <result pre="to reduce the mortalityInt J Antimicrob Agents2020110595410.1016/j.ijantimicag.2020.105954 79.SalazarMCet al.Association of" exact="Delayed" post="Adjuvant Chemotherapy with survival after lung cancer surgeryJAMA Oncol20173561061910.1001/jamaoncol.2016.582928056112"/>
  <result pre="Agents2020110595410.1016/j.ijantimicag.2020.105954 79.SalazarMCet al.Association of Delayed Adjuvant Chemotherapy with survival after" exact="lung cancer" post="surgeryJAMA Oncol20173561061910.1001/jamaoncol.2016.582928056112 80.ZhongW-Zet al.Gefitinib versus vinorelbine plus cisplatin as"/>
  <result pre="79.SalazarMCet al.Association of Delayed Adjuvant Chemotherapy with survival after lung" exact="cancer" post="surgeryJAMA Oncol20173561061910.1001/jamaoncol.2016.582928056112 80.ZhongW-Zet al.Gefitinib versus vinorelbine plus cisplatin as"/>
  <result pre="plus cisplatin as adjuvant treatment for stage II-IIIA (N1-N2) EGFR-mutant" exact="NSCLC" post="(ADJUVANT/CTONG1104): a randomised, open-label, phase 3 studyLancet Oncol201819113914810.1016/S1470-2045(17)30729-529174310 81.LeeYTTanYJOonCEMolecular"/>
  <result pre="randomised, open-label, phase 3 studyLancet Oncol201819113914810.1016/S1470-2045(17)30729-529174310 81.LeeYTTanYJOonCEMolecular targeted therapy: treating" exact="cancer" post="with specificityEur J Pharmacol201883418819610.1016/j.ejphar.2018.07.03430031797 82.SgambatoAet al.Targeted therapies in non-small"/>
  <result pre="immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell" exact="lung cancer" post="(CheckMate 063): a phase 2, single-arm trialLancet Oncol201516325726510.1016/S1470-2045(15)70054-925704439 85.KaragozogluSTekyasarFYilmazFAEffects"/>
  <result pre="checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung" exact="cancer" post="(CheckMate 063): a phase 2, single-arm trialLancet Oncol201516325726510.1016/S1470-2045(15)70054-925704439 85.KaragozogluSTekyasarFYilmazFAEffects"/>
  <result pre="2, single-arm trialLancet Oncol201516325726510.1016/S1470-2045(15)70054-925704439 85.KaragozogluSTekyasarFYilmazFAEffects of music therapy and guided" exact="visual" post="imagery on chemotherapy-induced anxiety and nausea-vomitingJ Clin Nurs2013221â€&quot;2395010.1111/jocn.1203023134272 86.RaghavendraRMet"/>
  <result pre="85.KaragozogluSTekyasarFYilmazFAEffects of music therapy and guided visual imagery on chemotherapy-induced" exact="anxiety" post="and nausea-vomitingJ Clin Nurs2013221â€&quot;2395010.1111/jocn.1203023134272 86.RaghavendraRMet al.Effects of an integrated"/>
  <result pre="an integrated yoga programme on chemotherapy-induced nausea and emesis in" exact="breast cancer" post="patientsEur J Cancer Care200716646247410.1111/j.1365-2354.2006.00739.x 87.LiuSet al.Online mental health services"/>
  <result pre="integrated yoga programme on chemotherapy-induced nausea and emesis in breast" exact="cancer" post="patientsEur J Cancer Care200716646247410.1111/j.1365-2354.2006.00739.x 87.LiuSet al.Online mental health services"/>
  <result pre="on chemotherapy-induced nausea and emesis in breast cancer patientsEur J" exact="Cancer" post="Care200716646247410.1111/j.1365-2354.2006.00739.x 87.LiuSet al.Online mental health services in China during"/>
  <result pre="the COVID-19 outbreakLancet Psychiatry202074e17e1810.1016/S2215-0366(20)30077-832085841 88.FujitaKet al.Impact of COVID-19 pandemic on" exact="lung cancer" post="treatment schedulingThorac Cancer202011 89.CalvoRADeterdingSRyanRMHealth surveillance during covid-19 pandemicBmj2020369m137310.1136/bmj.m137332253180 90.WangYet"/>
  <result pre="COVID-19 outbreakLancet Psychiatry202074e17e1810.1016/S2215-0366(20)30077-832085841 88.FujitaKet al.Impact of COVID-19 pandemic on lung" exact="cancer" post="treatment schedulingThorac Cancer202011 89.CalvoRADeterdingSRyanRMHealth surveillance during covid-19 pandemicBmj2020369m137310.1136/bmj.m137332253180 90.WangYet"/>
  <result pre="pandemicBmj2020369m137310.1136/bmj.m137332253180 90.WangYet al.Epidemiology of mental health problems among patients with" exact="cancer" post="during COVID-19 pandemicTransl Psychiatry202010126332737292 91.HoCSCheeCYHoRCMental health strategies to combat"/>
 </snippets>
</snippetsTree>
